Data as of Q4 2025 (Dec 31, 2025)

CONTINENTAL ADVISORS LLC

โ€ขCIK: 1277779โ€ขFiling: Q4 2025

CONTINENTAL ADVISORS LLC manages $197M across a portfolio of 37 positions. The fund exhibits significant concentration in the broad market via its top holding in SPY, valued at $61.4M. Further allocations include notable positions in pharmaceuticals and healthcare, such as PFE ($10.0M) and TEVA ($9.0M). This structure suggests a core focus on established market indices supplemented by targeted, sector-specific equity bets.

Total AUM
$123.5M
+ $73.1M in options
QoQ Performance
+2.1%
Positions
32
+ 5 options
Top 10 Concentration
64.4%
Latest Filing
Q4 2025

Top Holdings Allocation

SPY
PFE
SPY31.2%
PFE5.1%
TEVA4.6%
TFC4.0%
COF3.9%
FHI3.3%
UBER3.3%
TRVC3.2%

๐Ÿ“ˆ Biggest Buys

BMY
BRISTOL-MYERS SQUIBB CO
NEW
2.1% of portfolio
PFE
PFIZER INC
+42.7%
5.1% of portfolio
ALIT
ALIGHT INC
NEW
0.9% of portfolio
XLE
SELECT SECTOR SPDR TR
+100.0%
1.7% of portfolio
BAX
BAXTER INTL INC
NEW
0.6% of portfolio

๐Ÿ“‰ Biggest Sells

W3UCALL
WESTERN UN CO
-54.6%
2.2% of portfolio
VTRSCALL
VIATRIS INC
-55.9%
1.2% of portfolio
BPUT
BARRICK MNG CORP
-66.8%
0.7% of portfolio
TRVC
CITIGROUP INC
-26.1%
3.2% of portfolio
TEVA
TEVA PHARMACEUTICAL INDS LTD
-15.5%
4.6% of portfolio

Sector Breakdown

Other46.1%
ETF31.2%
Financial10.2%
Healthcare9.2%
Consumer3.3%

๐Ÿšช Exited Positionssold since Q3 2025

CNNE
CANNAE HLDGS INC
SOLD
$3.3M
VBTX
VERITEX HLDGS INC
SOLD
$448.0K
PROV
PROVIDENT FINL HLDGS INC
SOLD
$291.7K

Changes from Q3 2025

NEW4 new positions
โ†‘4 increased
โ†“18 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023